
    
      Any patient with osteoarthritis (OA) of the knee was invited to participate in the preceding
      trial. Eligible for this study will be patients, who have completed the one-year phase 2 of
      the CAROT. Exclusion criteria are planned knee alloplasty of both knees.
    
  